A Phase 4 interventional study of Levothyroxine and Calcium magnesia in Euthyroid Sick Syndrome, sponsored by Sinaloa Pediatric Hospital. Completed at 1 site in Mexico. Open to participants aged 1 Month to 17 Years. Per ClinicalTrials.gov, last updated 2014-03-05.
Sponsored by Sinaloa Pediatric Hospital · Phase 4, Interventional, and Treatment
The purpose of this study is to determine whether levothyroxine is effective and safe in the treatment of children with euthyroid sick syndrome, hospitalized in a pediatric intensive care unit.
Children with euthyroid sick syndrome, hospitalized in a pediatric intensive care unit, will be randomised to receive either Levothyroxine or placebo, to determine if it diminishes mortality.
Sinaloa Pediatric Hospital is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
3 mcg/kg/day
Drug: Levothyroxine
Calcium magnesia.
Other: Calcium magnesia
3 mcg/kg/day
Also known as: Brand: Eutirox.
Placebo.
All cause mortality
Time frame: participants will be followed for the duration of hospital stay, an expected average of 3 weeks
Length of time in intensive care
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Ventilation days
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Use of vasopressors
Time frame: participants will be followed for the duration of hospital stay, an expected average of 3 weeks
Thyroid hormones levels
Time frame: participants will be followed for the duration of hospital stay, an expected average of 3 weeks
This study is completed, as verified in Mar 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Thyroxine
Euthyroid Sick Syndromes
Sinaloa Pediatric Hospital